|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
DOI: 10.1080/2162402X.2019.1638210
Anna Kreutzman, Berit Markev？rn, Bhagwan Yadav, Bjorn Tore Gjertsen, Henrik Hjorth-Hansen, Jeroen Janssen, Jesper Stentoft, Johan Richter, Kourosh Lotfi, Leif Stenke, Lene Udby, Moon Hee Lee, Perttu Koskenvesa, Satu Mustjoki, Stina S？derlund, Tiina Kasanen, Tim H. Brummendorf, Ulla Olsson-Str？mberg
Keywords: CML, imatinib, bosutinib, Sokal, BCR-ABL
Abstract:
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
